Datavant

Overview

Datavant is the US healthcare data linkage and retrieval platform behind a series of acquired brands buyers may still search separately, including Ciox Health, Apixio, DigitalOwl, and Ontellus. Founded in 2017 as a Roivant Sciences spinout, Datavant built privacy-preserving tokenization that lets claims, EHR, lab, and mortality data be linked without exposing PHI; the Ciox merger added the dominant US medical-record retrieval and release-of-information business, and Apixio added risk-adjustment AI.

Aetion operates as Datavant’s regulatory-grade RWE subsidiary after the July 2025 acquisition. Datavant is not a hub services operator, a specialty pharmacy, or a commercial CRM; it is data infrastructure that other analytics, RWE, and operating vendors plug into.

Platform Capability Model

The framework below standardizes how Rx Almanac evaluates data-technology-platforms capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Datavant is evaluated as a US healthcare data linkage and retrieval platform behind acquired brands buyers may still search separately, including Ciox Health, Apixio, DigitalOwl, and Ontellus.

Capability	Buyer should compare	Datavant readout
Data aggregation and interoperability	Claims, EHR, CRM, pharmacy, provider, payer, and FHIR/API connectivity with normalization and identity resolution.	Major data foundation. Datavant Token is the de facto US patient-linkage layer for life sciences, providers, payers, and data partners.
Commercial analytics and patient finding	Targeting, segmentation, patient finding, provider analytics, referral leakage, and opportunity sizing.	Adjacent, not the use case. Datavant powers linkage that other commercial-analytics vendors build on; pair with a dedicated commercial-data vendor for direct targeting.
Workflow automation and CRM integration	Case workflows, field workflows, CRM, task automation, document handling, and operational queue management.	Core workflow layer. HealthForms (May 2024) and the broader ROI footprint cover provider-side workflows; CRM and commercial workflows belong to partners.
Provider, payer, and pharmacy network connectivity	Network reach across HCPs, payers, pharmacies, labs, health systems, and transaction endpoints.	Major network reach. Embedded ROI relationships with 80,000+ hospitals and clinics give Datavant retrieval scale that is hard to replicate.
AI, NLP, and unstructured data extraction	Conversation intelligence, document AI, NLP extraction, predictive models, and model monitoring.	Core automation workflow. Apixio-powered Clinical Insights Platform (enhanced March 2025) for HCC coding plus DigitalOwl for AI-assisted medical-record review.
Security, compliance, and governance	HIPAA, SOC2, data-use controls, auditability, consent, privacy, and regulated-workflow safeguards.	Major governance control. Datavant Privacy Hub and Expert Determination services are central to how regulated data linkage is contracted across the network.
Reporting, dashboards, and data delivery	Dashboards, exports, APIs, scheduled reporting, and downstream feeds to analytics or operating teams.	Reporting layer. Datavant supplies the linkage substrate that Aetion, partner RWE vendors, and customer analytics environments consume.

Buyer Fit

• Best-fit use case: Use Datavant when the operating need is privacy-preserving patient linkage across multiple datasets, medical-record retrieval at scale, or AI-assisted clinical-data review.
• Best-fit buyers: Pharma manufacturers, biotech, payers, providers, registries, and data partners that need linkage infrastructure rather than a packaged analytics product.
• Less ideal fit: Teams that only need a single commercial dataset, a hub services partner, or a turnkey CRO; pair Datavant with vendors built for those operating jobs.
• Commercial fit: Custom / RFP-led; pricing depends on token volume, ROI volume, data partner mix, AI module scope, and Aetion subsidiary involvement.
• Decision checks: Confirm permitted-use terms, downstream-licensing rights, partner-data flow, audit trail, and how Aetion engagements interlock with Datavant linkage contracts.

Differentiators

• Datavant Token network effect: Token-based linkage works only when partners adopt it; the install base across pharma, payers, providers, and data vendors is the platform’s primary moat.
• Embedded provider network: ROI relationships with 80,000+ hospitals and clinics translate into a high-yield medical-record retrieval footprint that purely digital competitors struggle to match.
• Clinical Insights Platform: Apixio-derived AI for HCC coding and risk adjustment is a separate product line buyers can purchase alongside linkage or retrieval.
• Aetion subsidiary: Datavant + Aetion combines tokenized linkage with regulatory-grade RWE analytics; KLAS 2026 #1 awards for Risk Adjustment Coding and Outsourced Coding reinforce the operating record.
• Privacy Hub and Expert Determination: Governance services that life-sciences customers cite as part of why they trust Datavant with regulated data.

RFP Questions

• Which products are in scope: Datavant Token linkage, medical-record retrieval, Clinical Insights / HCC coding, DigitalOwl review, or an Aetion-led RWE engagement?
• How is Datavant Token operationalized across the manufacturer’s existing data partners, and which datasets are already tokenized in production?
• What permitted uses, downstream-sharing rights, and AI-training restrictions apply to linked datasets?
• What for medical-record retrieval, what yield, turnaround time, denial-handling, and audit evidence is available in similar pharma use cases?
• How are Aetion engagements scoped against Datavant linkage contracts, including shared data rights, support, and governance?
• What model performance, validation methodology, and human-review controls govern Clinical Insights and DigitalOwl AI outputs?
• How are HIPAA expert determination, audit logs, and incident response handled across the integrated platform?

Recent Activity

• 2026-05 - Current Datavant materials emphasize 20-of-20 top life-sciences relationships, 350+ RWD partners, agentic AI / RWE direction, and Aetion integration; treat scale metrics as company-reported.

• 2026-04: Labcorp + AWS + Datavant launched an AI-powered RWD platform for Alzheimer’s research.

• 2026-04: Galway Global R&D Centre opened as a primary international hub.

• 2026-04: Datavant submitted formal CMS comments on Medicare Advantage risk adjustment, emphasizing careful implementation and AI-with-human-in-the-loop validation.

• 2026-02: Named #1 2026 Best in KLAS for Risk Adjustment Coding and Outsourced Coding.

• 2026-02: Thermo Fisher Scientific / PPD partnership embedded Datavant tokenization across PPD’s CorEvitas registries and Evidera solutions.

• 2025-10: Announced DigitalOwl acquisition to expand AI-assisted medical-record review.

• 2025-07: Completed acquisition of Aetion as the regulatory-grade RWE subsidiary.